Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022-Reference-Cited by-同舟云学术

Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022

Published:2022-06-16 Issue:24 Volume:27 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Pleininger Sonja¹,Indra Alexander¹,Golparian Daniel²,Heger Florian¹,Schindler Stefanie¹,Jacobsson Susanne²,Heidler Stefan³,Unemo Magnus⁴²

Affiliation:

1. Austrian Agency for Health and Food Safety, Vienna, Austria

2. WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

3. Urology Department, LKH Hochsteiermark, Leoben, Austria

4. Institute for Global Health, University College London, London, United Kingdom

Abstract

We describe a gonorrhoea case with ceftriaxone plus high-level azithromycin resistance. In April 2022, an Austrian heterosexual male was diagnosed with gonorrhoea after sexual intercourse with a female sex worker in Cambodia. Recommended treatment with ceftriaxone (1 g) plus azithromycin (1.5 g) possibly failed. Worryingly, this is the second strain in an Asian Neisseria gonorrhoeae genomic sublineage including high-level azithromycin-resistant strains that developed ceftriaxone resistance by acquisition of mosaic penA-60.001. Enhanced resistance surveillance and actions are imperative to prevent spread.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference23 articles.

1. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults.;Unemo;Int J STD AIDS,2020

2. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020.;St Cyr;MMWR Morb Mortal Wkly Rep,2020

3. World Health Organization (WHO). WHO guidelines for the treatment of Neisseria gonorrhoeae. Geneva: WHO; 2016. Available from: https://www.who.int/publications/i/item/9789241549691

4. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.;Tapsall;Expert Rev Anti Infect Ther,2009

5. The European response to control and manage multi- and extensively drug-resistant Neisseria gonorrhoeae.;Cole;Euro Surveill,2022

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study;Vaccine;2024-12

2. Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023;Emerging Infectious Diseases;2024-09

3. High-level ceftriaxone resistance due to transfer of penA allele 60.001 into endemic gonococcal lineages in Hangzhou, China;Journal of Antimicrobial Chemotherapy;2024-08-26

4. Direct sequencing technologies for bacterial sexually transmitted infections;Microbiology Australia;2024-08-02

5. Managing treatment failure in Neisseria gonorrhoeae infection: current guidelines and future directions;The Lancet Infectious Diseases;2024-08